Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Biogen Gross Profit 2006-2019 | BIIB

Biogen annual/quarterly gross profit history and growth rate from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Biogen gross profit for the quarter ending March 31, 2019 was $2.888B, a 7.55% increase year-over-year.
  • Biogen gross profit for the twelve months ending March 31, 2019 was $11.839B, a 8.59% increase year-over-year.
  • Biogen annual gross profit for 2018 was $11.637B, a 9.33% increase from 2017.
  • Biogen annual gross profit for 2017 was $10.644B, a 6.76% increase from 2016.
  • Biogen annual gross profit for 2016 was $9.97B, a 4.69% increase from 2015.
Biogen Annual Gross Profit
(Millions of US $)
2018 $11,637
2017 $10,644
2016 $9,970
2015 $9,523
2014 $8,532
2013 $6,075
2012 $4,971
2011 $4,582
2010 $4,316
2009 $3,995
2008 $3,696
2007 $2,836
2006 $2,409
2005 $2,049
Biogen Quarterly Gross Profit
(Millions of US $)
Q1 2019 $2,888
Q4 2018 $3,038
Q3 2018 $2,978
Q2 2018 $2,936
Q1 2018 $2,685
Q4 2017 $2,798
Q3 2017 $2,708
Q2 2017 $2,712
Q1 2017 $2,426
Q4 2016 $2,494
Q3 2016 $2,539
Q2 2016 $2,524
Q1 2016 $2,414
Q4 2015 $2,507
Q3 2015 $2,468
Q2 2015 $2,306
Q1 2015 $2,243
Q4 2014 $2,343
Q3 2014 $2,209
Q2 2014 $2,130
Q1 2014 $1,851
Q4 2013 $1,707
Q3 2013 $1,593
Q2 2013 $1,493
Q1 2013 $1,281
Q4 2012 $1,284
Q3 2012 $1,246
Q2 2012 $1,282
Q1 2012 $1,159
Q4 2011 $1,187
Q3 2011 $1,186
Q2 2011 $1,108
Q1 2011 $1,100
Q4 2010 $1,119
Q3 2010 $1,080
Q2 2010 $1,106
Q1 2010 $1,012
Q4 2009 $1,027
Q3 2009 $1,027
Q2 2009 $1,003
Q1 2009 $938
Q4 2008 $968
Q3 2008 $985
Q2 2008 $901
Q1 2008 $841
Q4 2007 $806
Q3 2007 $708
Q2 2007 $689
Q1 2007 $634
Q4 2006 $646
Q3 2006 $637
Q2 2006 $582
Q1 2006 $544
Q4 2005 $520
Q3 2005 $507
Q2 2005 $535
Q1 2005 $488
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $45.028B $13.453B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.508B 12.38
Gilead Sciences (GILD) United States $85.686B 10.40
Celgene (CELG) United States $64.115B 10.86
Vertex Pharmaceuticals (VRTX) United States $45.613B 55.14
Illumina (ILMN) United States $43.887B 50.86
CSL (CSLLY) Australia $36.043B 0.00
Regeneron Pharmaceuticals (REGN) United States $33.120B 15.57
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.639B 15.64
Incyte (INCY) United States $17.436B 70.70
Exact Sciences (EXAS) United States $15.096B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.897B 0.00
SINO PHARMACEUT (SBMFF) China $14.154B 0.00
Seattle Genetics (SGEN) United States $12.394B 0.00
Sarepta Therapeutics (SRPT) United States $11.244B 0.00
Genmab (GNMSF) Denmark $11.046B 56.15
Array BioPharma (ARRY) United States $10.373B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $8.989B 29.53
Galapagos (GLPG) Belgium $8.915B 0.00
Guardant Health (GH) United States $8.160B 0.00
Bio-Techne Corp (TECH) United States $8.121B 55.41
Alnylam Pharmaceuticals (ALNY) United States $8.085B 0.00
Bluebird Bio (BLUE) United States $7.786B 0.00
Exelixis (EXEL) United States $6.678B 17.02
Amarin (AMRN) Ireland $6.250B 0.00
BeiGene (BGNE) Cayman Islands $5.802B 0.00
Ascendis Pharma (ASND) Denmark $4.892B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.842B 0.00
Blueprint Medicines (BPMC) United States $4.799B 0.00
Moderna (MRNA) United States $4.692B 0.00
Horizon Pharma Public (HZNP) Ireland $4.554B 11.73
Repligen (RGEN) United States $4.146B 103.28
Mirati Therapeutics (MRTX) United States $3.817B 0.00
Alkermes (ALKS) Ireland $3.810B 0.00
Spark Therapeutics (ONCE) United States $3.771B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.770B 0.00
China Biologic Products (CBPO) China $3.686B 23.41
Ultragenyx Pharmaceutical (RARE) United States $3.590B 0.00
MorphoSys AG (MOR) Germany $3.514B 0.00
Arena Pharmaceuticals (ARNA) United States $3.071B 6.24
Amicus Therapeutics (FOLD) United States $3.053B 0.00
Immunomedics (IMMU) United States $2.931B 0.00
UniQure (QURE) Netherlands $2.819B 0.00
Medicines (MDCO) United States $2.740B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.631B 0.00
Reata Pharmaceuticals (RETA) United States $2.613B 0.00
MyoKardia (MYOK) United States $2.467B 0.00
Halozyme Therapeutics (HALO) United States $2.443B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.260B 0.00
Acceleron Pharma (XLRN) United States $2.260B 0.00
Ligand Pharmaceuticals (LGND) United States $2.259B 18.71
Emergent Biosolutions (EBS) United States $2.258B 19.61
NeoGenomics (NEO) United States $2.245B 147.00
Intercept Pharmaceuticals (ICPT) United States $2.135B 0.00
Zai Lab (ZLAB) China $2.087B 0.00
Genomic Health (GHDX) United States $2.083B 44.24
Akcea Therapeutics (AKCA) United States $2.047B 0.00
Denali Therapeutics (DNLI) United States $1.986B 0.00
Myriad Genetics (MYGN) United States $1.958B 19.47
REGENXBIO (RGNX) United States $1.826B 0.00
Insmed (INSM) United States $1.699B 0.00
Cambrex (CBM) United States $1.534B 19.40
Fate Therapeutics (FATE) United States $1.467B 0.00
RA PHARMCTL INC (RARX) United States $1.457B 0.00
AnaptysBio (ANAB) United States $1.432B 0.00
Sangamo Therapeutics (SGMO) United States $1.402B 0.00
Innoviva (INVA) United States $1.368B 3.78
Athenex (ATNX) United States $1.307B 0.00
Alector (ALEC) United States $1.291B 0.00
Coherus BioSciences (CHRS) United States $1.254B 0.00
Editas Medicine (EDIT) United States $1.214B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.189B 0.00
Epizyme (EPZM) United States $1.161B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.078B 0.00
Codexis (CDXS) United States $1.028B 0.00
Cara Therapeutics (CARA) United States $1.007B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.001B 0.00
ANI Pharmaceuticals (ANIP) United States $0.976B 17.31
Twist Bioscience (TWST) United States $0.976B 0.00
Zymeworks (ZYME) Canada $0.960B 0.00
Principia Biopharma (PRNB) United States $0.957B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.911B 0.00
Retrophin (RTRX) United States $0.886B 0.00
Adverum Biotechnologies (ADVM) United States $0.878B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.844B 0.00
Vericel (VCEL) United States $0.841B 0.00
WAVE Life Sciences (WVE) Singapore $0.825B 0.00
Arvinas (ARVN) United States $0.791B 0.00
Intellia Therapeutics (NTLA) United States $0.787B 0.00
Precision BioSciences (DTIL) United States $0.746B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.705B 33.28
Zealand Pharma (ZEAL) Denmark $0.691B 8.07
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Intra-Cellular Therapies (ITCI) United States $0.649B 0.00
Cytokineticsorporated (CYTK) United States $0.648B 0.00
Cellectis S.A (CLLS) France $0.634B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.631B 0.00
Heska (HSKA) United States $0.626B 64.12
Clovis Oncology (CLVS) United States $0.613B 0.00
DBV Technologies S.A (DBVT) France $0.606B 0.00
Stemline Therapeutics (STML) United States $0.604B 0.00
Anika Therapeutics (ANIK) United States $0.584B 19.94
Lexicon Pharmaceuticals (LXRX) United States $0.566B 0.00
Revance Therapeutics (RVNC) United States $0.566B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.560B 0.00
CytomX Therapeutics (CTMX) United States $0.555B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
MiMedx (MDXG) United States $0.516B 0.00
Mesoblast (MESO) Australia $0.493B 0.00
UROGEN PHARMA (URGN) United States $0.447B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.442B 0.00
PHARMA MAR SA (PHMMF) Spain $0.441B 0.00
Puma Biotechnology (PBYI) United States $0.407B 0.00
Prothena (PRTA) Ireland $0.399B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.17
Arcus Biosciences (RCUS) United States $0.380B 0.00
Biofrontera AG (BFRA) Germany $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
AC Immune SA (ACIU) Switzerland $0.370B 23.83
Gritstone Oncology (GRTS) United States $0.368B 0.00
Bellus Health (BLUSF) Canada $0.362B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.360B 0.00
Scholar Rock Holding (SRRK) United States $0.359B 0.00
Starpharma Holdings (SPHRY) Australia $0.355B 0.00
Avid Bioservices (CDMO) United States $0.351B 0.00
Albireo Pharma (ALBO) United States $0.350B 0.00
Merus (MRUS) Netherlands $0.341B 0.00
Agenus (AGEN) United States $0.340B 0.00
Kadmon Holdings (KDMN) United States $0.338B 0.00
BioDelivery Sciences (BDSI) United States $0.337B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.336B 0.00
Prometic Life Sciences (PFSCD) Canada $0.335B 0.00
Acorda Therapeutics (ACOR) United States $0.332B 5.84
Senesco Technologies (ELOX) United States $0.331B 0.00
Theratechnologies (THERF) Canada $0.331B 0.00
Syros Pharmaceuticals (SYRS) United States $0.321B 0.00
Sorrento Therapeutics (SRNE) United States $0.316B 0.00
Protagonist Therapeutics (PTGX) United States $0.311B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.304B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Inovio Pharmaceuticals (INO) United States $0.282B 0.00
Kindred Biosciences (KIN) United States $0.262B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.258B 0.00
Sutro Biopharma (STRO) United States $0.256B 0.00
PHASEBIO PHARMA (PHAS) United States $0.254B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.245B 0.00
Kamada (KMDA) Israel $0.240B 9.33
Dynavax Technologies (DVAX) United States $0.238B 0.00
Geron (GERN) United States $0.233B 0.00
ADMA Biologics Inc (ADMA) United States $0.224B 0.00
Athersys (ATHX) United States $0.223B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.222B 0.00
CorMedix Inc (CRMD) United States $0.215B 0.00
Palatin Technologies (PTN) United States $0.214B 0.00
Cel-Sci (CVM) United States $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.202B 0.00
Five Prime Therapeutics (FPRX) United States $0.202B 0.00
MannKind (MNKD) United States $0.201B 0.00
Cerecor (CERC) United States $0.198B 0.00
Affimed (AFMD) Germany $0.197B 0.00
Abeona Therapeutics (ABEO) United States $0.189B 0.00
Pfenex (PFNX) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.187B 0.00
Mersana Therapeutics (MRSN) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) $0.184B 0.00
Synlogic (SYBX) United States $0.183B 0.00
Arsanis (XFOR) United States $0.182B 0.00
Spero Therapeutics (SPRO) United States $0.179B 0.00
Enzo Biochem (ENZ) United States $0.178B 0.00
Compugen (CGEN) Israel $0.174B 0.00
BioTime (BTX) United States $0.171B 11.40
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.162B 0.00
XOMA (XOMA) United States $0.161B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.156B 0.00
Cue Biopharma (CUE) United States $0.154B 0.00
Strongbridge Biopharma (SBBP) United States $0.153B 8.81
Liquidia Technologies (LQDA) United States $0.144B 0.00
OvaScience (MLND) United States $0.143B 0.00
Adocia (ADOCY) France $0.140B 0.00
TOCAGEN INC (TOCA) United States $0.140B 0.00
Celyad SA (CYAD) Belgium $0.139B 0.00
Dyadic (DYAI) United States $0.136B 0.00
Northwest Biotherapeutics (NWBO) United States $0.129B 0.00
Seres Therapeutics (MCRB) United States $0.129B 0.00
Aptinyx (APTX) United States $0.127B 0.00
Alcobra (ARCT) United States $0.125B 0.00
NantKwest (NK) United States $0.124B 0.00
Aduro Biotech (ADRO) United States $0.118B 0.00
Verastem (VSTM) United States $0.117B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.116B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
Arbutus Biopharma (ABUS) Canada $0.111B 0.00
Novavax (NVAX) United States $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.105B 0.00
Menlo Therapeutics (MNLO) United States $0.104B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.103B 0.00
Checkpoint Therapeutics (CKPT) United States $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.101B 0.00
SESEN BIO, INC (SESN) United States $0.098B 0.00
Trevena (TRVN) United States $0.094B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.091B 0.00
Pluristem Therapeutics (PSTI) Israel $0.087B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.084B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.083B 0.00
Fortress Biotech (FBIO) United States $0.082B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.080B 0.00
Unum Therapeutics (UMRX) United States $0.080B 0.00
Selecta Biosciences (SELB) United States $0.077B 0.00
AquaBounty Technologies (AQB) United States $0.076B 0.00
Curis (CRIS) United States $0.075B 0.00
VBI Vaccines (VBIV) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Signal Genetics (MGEN) United States $0.072B 0.00
VTv Therapeutics (VTVT) United States $0.071B 0.00
Applied Genetic Technologies (AGTC) United States $0.071B 38.80
Oncobiologics (OTLK) United States $0.069B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.066B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.061B 0.00
Antibe Therapeutics (ATBPF) Canada $0.060B 0.00
ARAVIVE, INC (ARAV) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Protalix BioTherapeutics (PLX) Israel $0.057B 0.00
Invo BioScience (IVOB) United States $0.053B 0.00